Spanish company SureVision seeks funding for its new ocular technology
The Spanish technology company SureVision, a spin-off from the Institute of Optics of the Spanish National Research Council (CSIC), has taken an important step in its business development. The firm is currently participating in the BStartup Health event with the goal of completing its first funding round.
SureVision is known for the development of eyeDSR, an innovative system designed to improve visual quality. This technology seeks to offer advanced solutions in the field of optics, leveraging the high-level scientific research conducted at public centers in Spain.
The BStartup Health event is a key platform for emerging companies in the health sector. By participating in this initiative, SureVision hopes to attract investors interested in medical technologies that can transform the current market and improve patients' visual health.
Success in this investment round would allow the company to scale its production and bring its technology to market more quickly. Projects of this type demonstrate the importance of knowledge transfer from scientific laboratories to the private sector in Spain.
In conclusion, SureVision's progress is an example of the potential of Spanish science to generate competitive technological solutions at an international level. The coming months will be decisive in determining whether the company secures the necessary funds to consolidate its project.